5vp0: Difference between revisions
m Protected "5vp0" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 5vp0 is ON HOLD | The entry 5vp0 is ON HOLD | ||
Authors: | Authors: Hoffman, I.D. | ||
Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: | [[Category: Hoffman, I.D]] | ||